Migraines & headaches Board decisions

The Board granted service connection for a lower back condition and tinnitus, denied a higher rating for PTSD, and remanded the remaining claims for further development.

The Board granted an initial 50 percent rating for major depressive disorder and dismissed the appeals for increased rating of migraine headaches and service connection for a right elbow disability, while remanding claims for erectile dysfunction and neck condition.

The Board denied an initial compensable rating for bilateral hearing loss and remanded the claims for service connection for chronic headaches and obstructive sleep apnea.

The Board denied increased ratings for posttraumatic and tension headaches, hypertension, erectile dysfunction, tinnitus, and remanded several claims related to radiculopathy, ankle, thumb, and tinnitus. An effective date of May 3, 2019, was granted for the grant of service connection for right lower extremity radiculopathy impacting the femoral nerve.

The Board denied service connection for migraines and a neck disability, finding no evidence of current disabilities or in-service incurrence. The claim for an acquired mental health condition was remanded for further development.

The Board remands the claims for a rating in excess of 50 percent for PTSD, 30 percent for headaches, and 10 percent for cervical strain, as well as entitlement to TDIU, due to pre-decisional duty to assist errors.

The Board denied service connection for chronic fatigue syndrome, restless leg syndrome (both left and right lower extremities), headaches, and neck dermatosis due to a lack of evidence showing current disabilities.

The Board granted service connection for chronic fatigue syndrome, right temporomandibular joint dysfunction as secondary to PTSD, and an initial 30 percent disability rating for migraine headaches.

The Board remands the claims for service connection for OSA, bilateral pes planus, hypertension, migraines headaches, and an acquired psychiatric disorder due to a lack of adequate medical evidence regarding their etiology.

The veteran has formally requested the withdrawal of all pending appeals before the Board of Veterans' Appeals.

The Board denied service connection for chronic fatigue syndrome, chronic sinusitis, and lumbosacral strain but granted service connection for dermatitis as secondary to allergic rhinitis. The Board also granted a separate 10 percent rating for left foot plantar fasciitis and a 20 percent rating for cervical strain from May 31, 2024.

The Board granted an earlier effective date for the grant of service connection for migraines from January 10, 2024, and denied a higher initial disability rating.

The Board remands the claim for compensation under 38 U.S.C. § 1151 for migraines due to a VA surgery, as it requires additional evidence and an adequate medical opinion.

The Board granted a 50 percent rating for migraine headaches, as the Veteran experienced very frequent completely prostrating attacks productive of severe economic inadaptability.

The Veteran's service-connected migraine headaches are granted a 50 percent rating, while his chronic maxillary and frontal sinusitis is denied an initial compensable rating.

The Board granted service connection for dizziness, migraine headaches, right shoulder disability, left shoulder disability, and asthma, secondary to a service-connected condition. The claim for an initial compensable rating for syphilis was denied.

The Board granted service connection for cervical spine strain, left and right upper extremity radiculopathy, migraine headaches, and depressive disorder, finding that these conditions are secondary to the Veteran's service-connected disabilities.

The Board remands the case for a new VA examination to reassess the severity of the Veteran's service-connected tension headaches, as the last examination was conducted 7 years ago and the Veteran has reported worsening symptoms.

The Board remands the claims for service connection for a bilateral lung disability, hypertension, and migraine headaches due to insufficient evidence regarding their relationship to in-service toxic exposures.

The Board remands the claims for service connection for allergic rhinitis, tinea manus, headaches, vertigo, and conjunctival pigment bilateral associated with TERA participation prior to July 10, 2025, as additional development is required.